Ye Ding

1PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 28, 2025
Cost-effectiveness of talazoparib plus enzalutamide as first-line therapy in metastatic castration-resistant prostate cancer.

Jiaming Zhu, Zhengxiong Li, Ye Ding

Pageof 1

Frequent Collaborators

1 joint publications

Jiaming Zhu

1 joint publications

Zhengxiong Li

1 joint publications

Qiaoping Xu